Yumanity Therapeutics
Biotechnology company that transforms drug discovery for diseases caused by protein misfolding.
Launch date
Employees
Market cap
AUD31.7m
Enterprise valuation
AUD19m (Public information from Dec 2022)
Share price
$1.89 YMTX
Cambridge Massachusetts (HQ)
Authorizing premium user...